Immuron Limited risk profile

24 Normal where most of the sector sits

Measured 1 September 2026 from ANW's filed statements. Recomputed nightly.

24 (Normal), driven by Market expectation at 90, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation90AcuteStableDrawdown from the 52-week high — 66.3%
Operating pressure0ContainedStableCosts outgrowing revenue — -23.7 percentage points
Cash conversionReads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company.
Leverage and coverage35NormalStableInterest cover — -706.23x
Competitive position20NormalStableR&D-intensity gap against peers — -95.9 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Immuron Limited